DAT imaging in drug‐induced and psychogenic parkinsonism
Identifieur interne : 004139 ( Main/Exploration ); précédent : 004138; suivant : 004140DAT imaging in drug‐induced and psychogenic parkinsonism
Auteurs : Eduardo Tolosa [Espagne] ; Miguel Coelho [Espagne] ; Marisol Gallardo [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-10.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Biological transport, Brain (radionuclide imaging), Chemotherapy, Corpus Striatum (radionuclide imaging), DAT imaging, Diagnosis, Differential, Differential diagnostic, Dopamine, Human, Humans, Indication, Neural Pathways (radionuclide imaging), Neurodegenerative Diseases (radionuclide imaging), Parkinson Disease (radionuclide imaging), Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (psychology), Parkinson Disease, Secondary (radionuclide imaging), Parkinson's syndrome, Parkinsonism, Psychogenic, Psychophysiologic Disorders (radionuclide imaging), Sensitivity and Specificity, Single photon emission tomography, Substantia Nigra (radionuclide imaging), Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon, Toxicity, drug‐induced parkinsonism, nigrostriatal pathway, psychogenic parkinsonism.
- MESH :
- chemically induced : Parkinson Disease, Secondary.
- psychology : Parkinson Disease, Secondary.
- radionuclide imaging : Brain, Corpus Striatum, Neural Pathways, Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease, Secondary, Psychophysiologic Disorders, Substantia Nigra.
- Diagnosis, Differential, Humans, Sensitivity and Specificity, Tomography, Emission-Computed, Tomography, Emission-Computed, Single-Photon.
Abstract
Parkinson's syndrome (PS) is frequently encountered in disorders associated with prominent degeneration of the nigrostriatal pathway as in Parkinson's disease, multisystem atrophy, and progressive supranuclear palsy (presynaptic PS). Drug‐induced parkinsonism, a common, underdiagnosed health problem and psychogenic parkinsonism are causes of Parkinson's syndrome which, evidence suggests, occurs without degeneration of nigrostriatal structures. We review clinical features and results of DAT imaging in drug‐induced parkinsonism and psychogenic parkinsonism. These two conditions normally give normal striatal DAT imaging results; an abnormal result in either case could exclude both conditions, corroborating a diagnosis of organic parkinsonism in uncertain cases. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10575
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002032
- to stream Istex, to step Curation: 002032
- to stream Istex, to step Checkpoint: 002A69
- to stream PubMed, to step Corpus: 003681
- to stream PubMed, to step Curation: 003681
- to stream PubMed, to step Checkpoint: 003825
- to stream Ncbi, to step Merge: 000B83
- to stream Ncbi, to step Curation: 000B83
- to stream Ncbi, to step Checkpoint: 000B83
- to stream Main, to step Merge: 005D62
- to stream PascalFrancis, to step Corpus: 002350
- to stream PascalFrancis, to step Curation: 000971
- to stream PascalFrancis, to step Checkpoint: 002500
- to stream Main, to step Merge: 006046
- to stream Main, to step Curation: 004139
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">DAT imaging in drug‐induced and psychogenic parkinsonism</title><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name></author><author><name sortKey="Coelho, Miguel" sort="Coelho, Miguel" uniqKey="Coelho M" first="Miguel" last="Coelho">Miguel Coelho</name></author><author><name sortKey="Gallardo, Marisol" sort="Gallardo, Marisol" uniqKey="Gallardo M" first="Marisol" last="Gallardo">Marisol Gallardo</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:59BB28FF74E5C5593FDB6A7FE481CB5B4F38AA9D</idno><date when="2003" year="2003">2003</date><idno type="doi">10.1002/mds.10575</idno><idno type="url">https://api.istex.fr/document/59BB28FF74E5C5593FDB6A7FE481CB5B4F38AA9D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002032</idno><idno type="wicri:Area/Istex/Curation">002032</idno><idno type="wicri:Area/Istex/Checkpoint">002A69</idno><idno type="wicri:doubleKey">0885-3185:2003:Tolosa E:dat:imaging:in</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:14531043</idno><idno type="wicri:Area/PubMed/Corpus">003681</idno><idno type="wicri:Area/PubMed/Curation">003681</idno><idno type="wicri:Area/PubMed/Checkpoint">003825</idno><idno type="wicri:Area/Ncbi/Merge">000B83</idno><idno type="wicri:Area/Ncbi/Curation">000B83</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B83</idno><idno type="wicri:doubleKey">0885-3185:2003:Tolosa E:dat:imaging:in</idno><idno type="wicri:Area/Main/Merge">005D62</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:04-0115368</idno><idno type="wicri:Area/PascalFrancis/Corpus">002350</idno><idno type="wicri:Area/PascalFrancis/Curation">000971</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002500</idno><idno type="wicri:doubleKey">0885-3185:2003:Tolosa E:dat:imaging:in</idno><idno type="wicri:Area/Main/Merge">006046</idno><idno type="wicri:Area/Main/Curation">004139</idno><idno type="wicri:Area/Main/Exploration">004139</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">DAT imaging in drug‐induced and psychogenic parkinsonism</title><author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic Malaltias del Sistema Nervios, Hospital Clínic Universitari, University of Barcelona</wicri:regionArea><wicri:noRegion>University of Barcelona</wicri:noRegion></affiliation></author><author><name sortKey="Coelho, Miguel" sort="Coelho, Miguel" uniqKey="Coelho M" first="Miguel" last="Coelho">Miguel Coelho</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic Malaltias del Sistema Nervios, Hospital Clínic Universitari, University of Barcelona</wicri:regionArea><wicri:noRegion>University of Barcelona</wicri:noRegion></affiliation></author><author><name sortKey="Gallardo, Marisol" sort="Gallardo, Marisol" uniqKey="Gallardo M" first="Marisol" last="Gallardo">Marisol Gallardo</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic Malaltias del Sistema Nervios, Hospital Clínic Universitari, University of Barcelona</wicri:regionArea><wicri:noRegion>University of Barcelona</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2003-10">2003-10</date><biblScope unit="vol">18</biblScope><biblScope unit="issue">S7</biblScope><biblScope unit="supplement">7</biblScope><biblScope unit="page" from="S28">S28</biblScope><biblScope unit="page" to="S33">S33</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">59BB28FF74E5C5593FDB6A7FE481CB5B4F38AA9D</idno><idno type="DOI">10.1002/mds.10575</idno><idno type="ArticleID">MDS10575</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biological transport</term><term>Brain (radionuclide imaging)</term><term>Chemotherapy</term><term>Corpus Striatum (radionuclide imaging)</term><term>DAT imaging</term><term>Diagnosis, Differential</term><term>Differential diagnostic</term><term>Dopamine</term><term>Human</term><term>Humans</term><term>Indication</term><term>Neural Pathways (radionuclide imaging)</term><term>Neurodegenerative Diseases (radionuclide imaging)</term><term>Parkinson Disease (radionuclide imaging)</term><term>Parkinson Disease, Secondary (chemically induced)</term><term>Parkinson Disease, Secondary (psychology)</term><term>Parkinson Disease, Secondary (radionuclide imaging)</term><term>Parkinson's syndrome</term><term>Parkinsonism</term><term>Psychogenic</term><term>Psychophysiologic Disorders (radionuclide imaging)</term><term>Sensitivity and Specificity</term><term>Single photon emission tomography</term><term>Substantia Nigra (radionuclide imaging)</term><term>Tomography, Emission-Computed</term><term>Tomography, Emission-Computed, Single-Photon</term><term>Toxicity</term><term>drug‐induced parkinsonism</term><term>nigrostriatal pathway</term><term>psychogenic parkinsonism</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Brain</term><term>Corpus Striatum</term><term>Neural Pathways</term><term>Neurodegenerative Diseases</term><term>Parkinson Disease</term><term>Parkinson Disease, Secondary</term><term>Psychophysiologic Disorders</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term><term>Humans</term><term>Sensitivity and Specificity</term><term>Tomography, Emission-Computed</term><term>Tomography, Emission-Computed, Single-Photon</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Chimiothérapie</term><term>Diagnostic différentiel</term><term>Dopamine</term><term>Homme</term><term>Indication</term><term>Parkinsonisme</term><term>Psychogène</term><term>Tomoscintigraphie émission monophotonique</term><term>Toxicité</term><term>Transport biologique</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's syndrome (PS) is frequently encountered in disorders associated with prominent degeneration of the nigrostriatal pathway as in Parkinson's disease, multisystem atrophy, and progressive supranuclear palsy (presynaptic PS). Drug‐induced parkinsonism, a common, underdiagnosed health problem and psychogenic parkinsonism are causes of Parkinson's syndrome which, evidence suggests, occurs without degeneration of nigrostriatal structures. We review clinical features and results of DAT imaging in drug‐induced parkinsonism and psychogenic parkinsonism. These two conditions normally give normal striatal DAT imaging results; an abnormal result in either case could exclude both conditions, corroborating a diagnosis of organic parkinsonism in uncertain cases. © 2003 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name></noRegion><name sortKey="Coelho, Miguel" sort="Coelho, Miguel" uniqKey="Coelho M" first="Miguel" last="Coelho">Miguel Coelho</name><name sortKey="Gallardo, Marisol" sort="Gallardo, Marisol" uniqKey="Gallardo M" first="Marisol" last="Gallardo">Marisol Gallardo</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004139 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004139 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:59BB28FF74E5C5593FDB6A7FE481CB5B4F38AA9D
|texte= DAT imaging in drug‐induced and psychogenic parkinsonism
}}
| This area was generated with Dilib version V0.6.23. |  |